The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlethora Solutions Holdings Plc Share News (PLE)

  • There is currently no data for PLE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Regent Pacific To Acquire Plethora Solutions For GBP114.3 Million

Tue, 15th Dec 2015 13:47

LONDON (Alliance News) - Regent Pacific Group Ltd on Tuesday said it has agreed to acquire the shares it doesn't already own in Plethora Solutions Holdings PLC, valuing the premature ejaculation treatment company at 11.65 pence per share.

The deal values Plethora at about GBP95.9 million, based on the number of shares in issue, and at GBP114.3 million when considering its fully diluted share capital. Shareholders in Plethora will receive 15.7076 new Regent Pacific shares for each Plethora share they own. Shares in Plethora jumped by 18% to 5.30p on Tuesday afternoon.

The deal comes about six weeks after the companies said they had agreed on the key terms of a possible deal.

James Mellon is the non-executive chairman of Plethora and non-executive co-chairman of Regent Pacific, and Jamie Gibson is an executive director and the chief executive of both companies. Plethora's main product is PSD502, a treatment for premature ejaculation.

On completion of the offer, Plethora shareholders other than Regent Pacific will own about 65.98% of the combined group.

"This offer is about optimising growth and realising the potential of an innovative product that can address a known medical condition affecting almost one in four men. With increased investment and commercial innovation, we see huge scope for the product initially in Europe where it has approval, and in the important US market and in the fast growing Asian market in due course," James Mellon said.

"We view the offer as taking account of PSD502TM's prospects, while also providing a compelling premium of more than 38% to the price at which Plethora's last issued shares in August 2014 and we believe it will create significantly more future value than Plethora could achieve independently," Mellon added.

Michael Wyllie, chief science officer at Plethora, said the deal presents an "achievable solution to its difficult financial position whilst providing shareholders an opportunity to maintain an ongoing economic interest in Plethora and its product".

By Samuel Agini; samagini@alliancenews.com; @samuelagini

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
16 Sep 2014 07:57

Plethora Surges On PSD502 Licensing Deal With Recordati

Read more
29 Aug 2014 14:22

Plethora Solutions Targets Fundraise As Losses Widen

Read more
10 Jun 2014 07:29

UK MORNING BRIEFING: ASOS Replaces Sports Direct As Conviction Buy

LONDON (Alliance News) - UK shares have opened mixed Tuesday, with AIM marginally outperforming larger stocks.

Goldman Sachs joined other brokers in issuing positive notes about AIM giant ASOS following its recent share price decline. Goldman added ASOS to its Convi

Read more
10 Jun 2014 05:12

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar
Tuesday, June 10
Read more
9 Jun 2014 14:51

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar
Tuesday, June 10
Read more
6 Jun 2014 05:24

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar
Friday, June 6
Read more
5 Jun 2014 15:08

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar
Friday, June 6
Read more
5 Jun 2014 05:10

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar
Thursday, June 5
Read more
4 Jun 2014 15:29

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar
Thursday, June 5
Read more
4 Jun 2014 05:14

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar
Wednesday, June 4
Read more
3 Jun 2014 15:10

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar
Wednesday, June 4
Read more
19 May 2014 09:11

Plethora Share Capital Shrinks After Urology Loan Partly Repaid

LONDON (Alliance News) - Plethora Solutions Holdings PLC Monday said its share capital will shrink after the administrators for its Urology Co business said it would pay off part of a loan that the unit owed. Plethora in February said it had decided to appoint administrators for Urology Co,

Read more
22 Apr 2014 12:21

Plethora Solutions Loss Widens On Costs, Cessation Of Subsidiary

LONDON (Alliance News) - Plethora Solutions Holdings PLC Tuesday posted a widened pretax loss, hit by the cessation of its business The Urology Co and higher costs, as it ramps up development of its premature ejaculation treatment PSD502. The speciality pharmaceutical company posted a preta

Read more
22 Apr 2014 11:44

Plethora droops on increased losses

Shares in sexual health specialist Plethora Solutions drooped on news that the company made increased losses last year. On the upside, Plethora confirmed it has now settled on an "unambiguous defined path" for a successful submission for a US regulatory application for its lead product, 'PSD502', a

Read more
26 Mar 2014 12:31

Plethora Appoints Manufacturer For Premature Ejaculation Canister

LONDON (Alliance News) - Plethora Solutions Holdings PLC said Wednesday it has appointed Pharmaserve North West Limited to manufacture the new six dose canister for its premature ejaculation solution, PSD502. PSD502 is a topical spray for the treatment of premature ejaculation, containing l

Read more

Quickpicks are a member only feature

Login to your account